共 130 条
[1]
Mailloux LU(1998)Hypertension in the ESRD patient: pathophysiology, therapy, outcomes, and future directions Am J Kidney Dis 32 705-719
[2]
Haley WE(2012)Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis Lancet 380 1649-1661
[3]
Mahmoodi BK(2014)Assessment and management of hypertension in patients on dialysis J Am Soc Nephrol JASN 25 1630-1646
[4]
Matsushita K(2016)Hypertension in chronic kidney disease part 1: out-of-office blood pressure monitoring: methods, thresholds, and patterns Hypertension (Dallas, Tex.: 1979) 67 1093-1101
[5]
Woodward M(2011)Early sympathetic activation in the initial clinical stages of chronic renal failure Hypertension (Dallas, Tex.: 1979) 57 846-851
[6]
Agarwal R(1992)Sympathetic overactivity in patients with chronic renal failure N Engl J Med 327 1912-1918
[7]
Flynn J(2002)Sympathetic nerve activity in end-stage renal disease Circulation 106 1974-1979
[8]
Pogue V(2010)Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial Lancet 376 1903-1909
[9]
Rahman M(2014)A controlled trial of renal denervation for resistant hypertension N Engl J Med 370 1393-1401
[10]
Reisin E(2017)Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial Lancet 390 2160-2170